Michelle Ferreira, DO

Michelle Ferreira, DO

Michelle Ferreira, DO

Michelle Ferreira, DOMichelle Ferreira, DO is a Board Certified Neurologist and is Fellowship trained in Movement Disorders. Dr. Ferreira received her medical degree from Nova Southeastern University in Ft. Lauderdale, FL. Her residency was done in University of Miami, Jackson Memorial Hospital, and her Fellowship completed in Cleveland Clinic Florida. Dr. Michelle Ferreira’s unique holistic approach and genuine caring for her patients results in a more satisfying visit experience.

Dr. Michelle Ferreira evaluates and treats patients with strokes, Parkinson’s disease, dementia, seizures, neuropathy, headaches, Gait disorders, Multiple Sclerosis, and Familial Tremor. Dr. Ferreira unique holistic approach and genuine caring for her patients results in a more satisfying visit experience.Dr. Ferreira is a member of the American Academy of Neurology, Movement Disorders Society, American Medical Association, and Florida Medical Osteopathic Association. Dr. Ferreira volunteers at Clinical Preceptor for Medical Students at Nova Southeastern College of Osteopathic Medicine and currently an assistant clinical professor at NSU. Dr. Ferreira lectures for Internal Medicine Residents at Palmetto General Hospital, Miami.


Dementia, Multiple Sclerosis, Parkinson’s Disease, Stroke

Board Certifications
American Board of Psychiatry and Neurology

Medical Interests
Deep Brain Stimulation in Parkinson’s Disease and tremors
Botulinum toxin therapies for Neurological Disease (Ie. Botox) Parkinson and Parkinson’s Plus Syndromes Migraine Disorders Trigeminal Neuralgia Small Fiber Neuropathy Novel Treatments in Multiple Sclerosis Infusions For Neurological Disorders
Psychogenic Movement Disorders

Nova Southeastern University, Ft. Lauderdale, FL

Adult Neurology Resident
Jackson Memorial Hospital/University of Miami, Miami, FL Jul. 2008-June 2011

Movement Disorder Fellowship / Staff Neurologist Cleveland Clinic Florida, Weston, FL Jul 2011 – June 2012

American Medical Association (AMA) 2013-Present
American Academy of Neurology 2008-Present
Movement Disorder Society 2011-Present
Florida Society of Neurology 2009-Present
Florida Osteopathic Medical Association 2012-Present
American Student Medical Association 2000-2002

Awards & Accolades
Clinical Preceptor for Medical Students at Nova Southeastern College of Osteopathic Medicine.

Lecturer for Internal Medicine Residents at Palmetto General Hospital, Miami.

Board Certification by the American Board of Psychiatry and Neurology Sept. 2012 – 2022 # 57489

Florida Medical License, Florida, OS 11301, active

Controlled Substance Registration Certificate, Active

NIH Stroke Scale Certification, American Heart Association, 2008-Present

Deep Brain Stimulation Programming, Medtronic Certification 2011

Research & Clinical Trials
Genzyme OBS13434-A Prospective, Multicenter, Observational, Post-Authorization Study To Evaluate The Long-Term Safety Profile Of Lemtrada Treatment In Patients With Relapsing Forms Of Multiple Sclerosis.

Avanir 15-AVP-786-301-A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy, Safety And Tolerability Of AVP-786 For The Treatment Of Agitation In Patient With Dementia Of The Alzheimer’s Type.

Luitpold 1VIT13037 – A double-blind, multi-center, randomized, placebo-controlled study to investigate the efficacy and safety of Injectafer (Ferric Carboxymaltose) in the treatment of Restless Legs Syndrome (RLS) Bayer Healthcare/Xcenda 17942 – Impact of the BETACONNECT auto-injector on BETASERON therapy adherence and patient satisfaction

Amgen 20150133 Evidera A-16821 – A prospective observational study to evaluate tolerability and outcomes of prophylactic therapies in Migraines BioDelivery BDSI BNX-401 – Prospective Evaluation of Treatment Satisfaction with Buprenorphine/Naloxone Buccal Film in Opioid-Dependent Subjects

Biogen POP 105MS401 – Plegridy Observational Program to assess the overall long-term clinical effectiveness of Plegridy in participants with relapsing forms of MS

Hoffman La-Roche VANILLA BP28420E – A multi-center, randomized, double-blind, 12-week parallel group, placebo-controlled proof of concept study to investigate the efficacy and safety of RO5285119 in individuals with Autism spectrum disorders (ASD)

Novartis EXPAND CBAF312A2304 – Evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis

Novartis PASSAGE FTY720D3403 – Safety Study in Patients with Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

PET STUDY DCA-2 – Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship between Scan Status and Cognitive Decline in Alzheimer’s Patients

UCB Bioscience SP0993 – Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older Novartis

PREFERMS CFTY720DUS09 –Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients with Relapsing-Remitting Multiple Sclerosis

PET STUDY DCA-1 – Potential of Florbetapir F18 PET to Inform Clinical Diagnosis and Management of Alzheimer’s Patients with Progressive Cognitive Decline

Ipsen A-TL 52150-56 Anchor-DC – DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

Accepts New Patients

English, Spanish

Google Reviews

9970 Central Park Boulevard, Suite 207
Boca Raton, FL 33428
Phone: (561) 482-1027
Fax: (561) 482-1028

4600 Linton Boulevard, Suite 240
Delray Beach, FL 33445
Phone: (561) 482-1027
Fax: (561) 482-1028

1825 N. Pine Island Road
Plantation, FL 33322
Phone: (561) 482-1027
Fax: (561) 482-1028

Monday: 9:00 a.m. – 5:00 p.m.
Tuesday: 7:30 a.m. – 5:00 p.m.
Wednesday: 9:00 a.m. – 5:00 p.m.
Thursday 7:30 a.m. – 5:00 p.m.
Friday: 9:00 a.m. – 5:00 p.m.

Hospital Affiliations
West Boca Medical Center


Michelle Ferreira, DO is a neurologist located in Boca Raton and Plantation, Florida. You can contact her office at (561) 482-1027.

  • Michelle Ferreira, DO
  • Michelle Ferreira, DO